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INTRODUCTION
Haemopoietic stem cells (HSC) in the bone marrow (BM) give rise to 
monocytes in circulation which can then enter tissues to become 
resident macrophages. Mammalian macrophages are numerous in 
all tissues, and apart from their role in the innate immune response 
are required for many aspects of development and homeostasis 
(reviewed in ref. 1). Macrophages are also involved in the pathogen-
esis of inflammatory diseases such as atherosclerosis2 and rheuma-
toid arthritis3 and in the initiation, progression, and metastasis of 
tumors.4 The active recruitment of monocyte-macrophages in all 
forms of inflammation makes them an attractive candidate for ther-
apeutic gene delivery. Gene-targeted macrophages could therefore 
be an effective method to focus protein expression to the site of 
diseased tissues and nearby blood vessels. Macrophages can cross 
the blood–brain barrier and therefore could deliver proteins to the 
brain in the treatment of neurological disorders.5 Macrophage lin-
eage cells function as antigen-presenting cells (APC) for the acti-
vation of T lymphocytes.6 Restricted expression in vaccine vectors 
could provide increased immunogenicity by avoiding expression in 
non-APC, where the outcome may be tolerogenic.
A feature of macrophages is the high expression of lysosomal 
enzymes.7 Lineage-restricted gene therapy has been considered in 
the treatment of lysosomal storage diseases and other phagocyte 
defects. Lysosomal storage diseases are a large group of meta-
bolic disorders caused by a deficiency in lysosomal enzymes.8 In 
affected patients, these defects are most obvious in macrophages. 
Phagocyte function is specifically compromised in chronic granulo-
matous disease where defects in genes coding for components of 
the NADPH oxidase enzyme system result in impaired macrophage 
function.9 A recent study by Brendel et al.10 used a novel myeloid-
specific mIR223 promoter for chronic granulomatous disease ther-
apy in mice. While expression of p47(PHOX) and gp91(PHOX) was 
targeted to granulocytes and macrophages, expression was also 
detected in other cells such as HSC and lymphocytes.
Colony-stimulating factor 1 receptor (Csf1r) is a member of the 
type III protein tyrosine kinase receptor family whose expression 
in adults is restricted to cells of the macrophage lineage.11 We have 
previously identified the elements of the Csf1r locus required for 
lineage-restricted expression in the MacGreen reporter mice.12 The 
construct contained a 7.2kb region comprising the promoter and 
first intron, which includes a critical conserved enhancer termed 
the Fms-intronic regulatory element (FIRE). A construct of this size 
is clearly not practical for gene therapy. Here, we have extracted 
sequences of the mouse Csf1r promoter and FIRE to create various 
lentiviral vectors. These vectors drive expression of several different 
reporter genes in monocytes and macrophages in a variety of spe-
cies, including human, rat, pig, cow, sheep, and chicken. Aside from 
the practical applications for delivery to macrophages, the results 
indicate that the high sequence conservation of FIRE is reflected in 
conserved functional activity from birds to mammals.
RESULTS
The Csf1r promoter and FIRE drives EGFP and mCherry expression 
in RAW264.7 cells
Our recent study suggested that the function of FIRE, in situ, is position 
and orientation dependent,13 but it has previously been reported to 
have conventional enhancer activity.14 In order to drive expression of 
enhanced green fluorescent protein (EGFP) specifically in monocytes 
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The development of macrophages requires signaling through the lineage-restricted receptor Csf1r. Macrophage-restricted expres-
sion of transgenic reporters based upon Csf1r requires the highly conserved Fms-intronic regulatory element (FIRE). We have 
created a lentiviral construct containing mouse FIRE and promoter. The lentivirus is capable of directing macrophage-restricted 
reporter gene expression in mouse, rat, human, pig, cow, sheep, and even chicken. Rat bone marrow cells transduced with the 
lentivirus were capable of differentiating into macrophages expressing the reporter gene in vitro. Macrophage-restricted expres-
sion may be desirable for immunization or immune response modulation, and for gene therapy for lysosomal storage diseases 
and some immunodeficiencies. The small size of the Csf1r transcription control elements will allow the insertion of large “cargo” for 
applications in gene therapy and vaccine delivery.
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and macrophages, the Csf1r promoter (including start codon) was 
fused to the coding sequence of EGFP and cloned upstream of FIRE in a 
lentiviral vector (Figure 1). mCherry constructs (data not shown) were 
also created as well as one in which expression of EGFP or mCherry 
was localized to membranes using a myristoylated motif (Figure 1c). 
The specificity of the lentivirus was initially tested by transduction of 
the murine cell lines EL4 (T lymphocyte) and RAW264.7 (monocyte/
macrophage) with Csf1r:EGFP-FIRE. After 10 days of selection in blas-
ticidin, only RAW264.7 cells expressed EGFP when viewed by confo-
cal microscopy (Figure 2a). Cells transduced with Csf1r:myr:EGFP-FIRE 
displayed EGFP expression at slightly lower levels via flow cytometry 
(Figure 2b). However, in these cells, as anticipated, the EGFP was only 
localized to the cell membrane and also to membranes of intracellu-
lar vesicles (Figure 2c). Lentiviral transduction of RAW264.7 cells with 
the alternative vector containing mCherry also resulted in reporter 
expression as detected by confocal microscopy (Figure 2c). In sum-
mary, with all reporters, the expression was not only restricted to 
macrophages, but was sufficient to enable ready visualization.
Primary rat macrophages transduced with Csf1r:EGFP-FIRE 
lentivirus express EGFP
We currently have Csf1r-EGFP-positive transgenic mice, which have 
been widely used.12 A similar reporter in rat would have great util-
ity, but rat transgenesis is less straightforward and lentiviral deliv-
ery would provide an alternative route. The Csf1r:EGFP-FIRE lentivi-
rus was also active in primary cells and in the rat. Rat BM-derived 
macrophages were transduced with the lentivirus and the major-
ity of transduced cells were EGFP+ as determined by fluorescent 
microscopy (Figure 3a). We therefore wished to determine whether 
the virus, once integrated into progenitors, would maintain expres-
sion during differentiation. Rat BM cells were cultured for 2 days 
in IL-3, IL-6, and stem cell factor (SCF) to support myeloid progeni-
tors and then transduced with Csf1r:EGFP-FIRE. Two days following 
transduction, growth factors were replaced with rhCSF1 to allow 
macrophage development. Prior to addition of rhCSF1, few cells 
were EGFP+ (Figure 3b, i), but as the cells differentiated into mac-
rophages, the number of EGFP+ increased. After 7 days, the large 
majority of cells were EGFP+ (Figure 3b, iii) and were confirmed as 
functional macrophages by their ability to phagocytose fluores-
cently labeled zymosan particles (Figure 3b, iv).
Csf1r:EGFP-FIRE drives EGFP expression exclusively in cells 
expressing Csf1r
To confirm the specificity of Csf1r:EGFP-FIRE, rat BM cells were 
transduced with the lentivirus after 2 days in culture and reverse 
Figure 1  Csf1r:EGFP lentiviral constructs. Schematic of murine Csf1r:EGFP 
constructs. All constructs contained a blasticidin-resistance gene (BSD) 
driven by the EM7/SV40 promoter. (a) Csf1r:EGFP-FIRE (b) Csf1r:EGFP-sFIRE 
(c) Csf1r:myr:EGFP-FIRE. cPPT, central polypurine tract; FIRE, Fms-Intronic 
Regulatory Element; ψ, HIV-1 packaging signal; LTR, long terminal repeat; 
RRE, rev response elements; sFIRE, short FIRE; myr, myristoylated motif.
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Figure 2 Murine Csf1r elements in a lentivirus drive reporter gene expression in macrophages but not T lymphocytes. (a) Representative confocal 
microscopy images of EL4 and RAW264.7 cells transduced (n = 3) with Csf1r:EGFP-FIRE. (b) FACS analysis of RAW264.7 cells transduced with Csf1r:EGFP-
FIRE or a membrane-bound EGFP (Csf1r:myr:EGFP-FIRE). (c) RAW264.7 cells transduced with (i) Csf1r:myr:mCherry-FIRE and Csf1r:EGFP-FIRE, 
(ii) Csf1r:myr:EGFP-FIRE, (iii) and Csf1r:mCherry-FIRE. Bar = 20µm or 10µm in C i and iii.
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transcriptase PCR performed for Csf1r expression in sorted GFP− 
and GFP+ populations following selection in blasticidin. Cells were 
cultured in the presence of IL-6, FLT3-L, thrombopoietin, and SCF 
to support the growth of progenitors and provide a mixture of hae-
mopoietic lineages for analysis. Three weeks following transduction, 
approximately one quarter of the cells expressed EGFP (Figure 3c) and 
only these cells expressed Csf1r as determined by reverse transcrip-
tase PCR (Figure 3d). These results confirm that Csf1r:EGFP-FIRE drives 
EGFP expression only in haemopoietic cell types expressing Csf1r.
A lentivirus containing a smaller region of intronic DNA results in 
EGFP expression but at lower levels in RAW264.7 cells
The plasmid encoding Csf1r:EGFP-FIRE consists of 6.5 kb sequence 
between the two lentiviral long terminal repeats (LTR). To increase 
the potential “cargo” capacity available for expression of genes 
of interest, we created a smaller vector (Csf1r:EGFP-sFIRE), which 
reduced the region surrounding FIRE by around 1.2 kb, so that there 
was only 5.3 kb between LTRs. The truncated construct retained 
EGFP expression, albeit at a slightly lower level compared to 
Csf1r:EGFP-FIRE (Figure 3e).
Murine Csf1r:EGFP-FIRE drives expression of EGFP in macrophages 
from multiple species
The FIRE element is highly conserved from birds to humans. We 
therefore examined whether murine Csf1r:EGFP-FIRE could direct 
the expression of EGFP in macrophages of other species. Figure 4 
clearly shows EGFP expression in BM-derived macrophages from 
pig (Figure 4a), monocyte-derived macrophages from cow (Figure 
4b) and human (Figure 4c) as well as a chicken macrophage cell line 
(HD11, Figure 4d), and sheep alveolar macrophages (Figure 4e).
DISCUSSION
Differentiation of BM progenitors into macrophages requires macro-
phage colony-stimulating factor (Csf1), which signals via its receptor 
Csf1r.15,16 Expression of Csf1r mRNA in mice is restricted to cells of 
the myeloid lineage. The only other expression occurs in placental 
trophoblasts during development, where it is driven by a distinct 
promoter.17 MacGreen mice were created previously by placing EGFP 
expression under the control of the Csf1r proximal promoter and 
FIRE located in the first intron.12 These mice have consistent expres-
sion of EGFP in the same locations as the endogenous gene and 
Figure 3 Csf1r:EGFP-FIRE can transduce primary rat macrophages and EGFP expression is restricted to haemopoietic cells expressing Csf1r. (a) Rat 
bone marrow (BM) cells were differentiated into macrophages with rhCSF1 then transduced with Csf1r:EGFP-FIRE. Bar = 50 µm. (b) Rat BM cells were 
cultured in interleukin (IL)-6, IL-3, and SCF and transduced with Csf1r:EGFP-FIRE, then differentiated into macrophages with rhCSF1 and images taken 
via confocal microscopy on days (i) 0, (ii) 3, and (iii) 7 of differentiation. (iv) A phagocytosis assay was performed on transduced macrophages. Bar = 50 
µm. (c) Rat BM cells were cultured in IL-6, FLT3-L, TPO, and SCF and transduced with Csf1r:EGFP-FIRE. After 3 weeks in selection with blasticidin, cells 
were FACS sorted for EGFP− and EGFP+ populations. (d) mRNA was prepared from sorted EGFP− and EGFP+ populations and used in RT-PCR to analyze 
Csf1r expression. Each image is representative of two experiments. (e) Murine RAW264.7 cells were transduced with 1 × 105 viral titer units per 3 × 105 
cells and FACS analysis performed for EGFP expression following blasticidin selection. Histogram is representative of three independent experiments. 
RT-PCR, reverse transcriptase PCR; SCF, stem cell factor; TPO, thrombopoietin.
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provide a valuable tool for those interested in macrophage biology. 
Lentiviral gene delivery to embryos results in higher percentages of 
transgenic animals when compared to standard pronuclear injection 
techniques.18 The region of Csf1r used to create the MacGreen mice 
(7.2 kb) was considered too large to incorporate into a lentiviral vec-
tor. Including EGFP, the sequence between the two LTRs would be 
10.5 kb. HIV-based lentiviral vectors generally contain a maximum 
sequence of 9 kb between the two LTR as this is the size of the native 
HIV genome.19 Insertion of larger sequences is possible but typically 
results in lower titers of virus.20 To enable inclusion of cargo, we cre-
ated a vector in which a 0.5 kb region of the murine Csf1r promoter 
was placed 5′ to the EGFP coding sequence with a distal portion of 
the Csf1r second intron containing FIRE (1.8 kb) placed 3′ to the EGFP 
stop codon. We also created a smaller vector, in which the region sur-
rounding FIRE was further reduced. This decreased expression some-
what, possibly due to the exclusion of a second known DNase hyper-
sensitive site upstream of FIRE.14 Both vectors enabled expression of 
the EGFP reporter. We also tested a membrane-targeted reporter. 
Myristoylation is a protein modification and one of the mechanisms 
involved when a protein associates with a membrane.21 When this 
motif was fused to EGFP in the construct Csf1r:myr:EGFP-FIRE and 
used to transduce cells, it resulted in EGFP that was not only localized 
to the cell membrane but also to membranes of intracellular vesicles. 
This would therefore be useful in colocalisation studies as pathogens 
are known to assemble within endosomes22 and phagosomes23 and 
would also aid the visualization of pseudopodia during infection.
Rat BM cells were capable of differentiation into EGFP+ macro-
phages following transduction with the Csf1r:EGFP-FIRE lentivirus 
highlighting both the potential use of this vector in gene therapy 
and its lineage-restricted expression. Although there remains a 
formal need to confirm that the vector would be induced during 
human macrophage differentiation from progenitors, the FIRE ele-
ment is highly conserved and also enters open chromatin during 
human macrophage differentiation.24 Current gene therapy strate-
gies are based on ex vivo transduction of autologous HSC with viral 
vectors containing therapeutic genes. Recent studies in humans 
have highlighted the benefit of HSC gene therapy in metachromatic 
leukodystrophy, a neurodegenerative lysosomal storage disease. 
Metachromatic leukodystrophy patients are deficient in arylsulfatase 
A causing build-up of the enzyme’s substrate in various cell types 
including microglia and macrophages of the peripheral nervous sys-
tem.25 Biffi et al. 26 reported promising results in a phase 1/2 clinical 
trial involving three patients where HSC were transduced with a len-
tivirus overexpressing arylsulfatase A from a ubiquitous promoter. 
Gene delivery driven by such promoters could have undesirable 
effects in nontarget cell types, and current lentivirus-based technolo-
gies aim to deliver proteins only to target cells. As macrophages have 
the potential to deliver therapeutic proteins to many target tissues, 
they make an attractive target cell for gene therapy. Several macro-
phage promoters such as CD68 and the scavenger receptor-A have 
been studied. Their limitations are reviewed in ref. 27. He et al.28 gen-
erated macrophage-specific synthetic promoters by random liga-
tion of myeloid/macrophage cis elements and reported that these 
promoters were 100-fold more effective at delivering green fluores-
cent protein (GFP) to macrophage cell lines than the native Csf1r pro-
moter. However, their Csf1r constructs did not include the intronic 
region containing FIRE, which is essential for EGFP expression in the 
MacGreen mice, so the baseline for comparison was very low.12 The 
promoter of CD68 has been suggested as the best currently avail-
able macrophage-specific promoter,29 but CD68 reporter mice do 
not express GFP in the majority of cells expressing F4/80,30 which is a 
well-documented marker of macrophages.31 For myeloid-restricted 
gene expression, the Csf1r promoter/enhancer appears superior in 
terms of efficacy, specificity, and reproducibility. The production of 
transgenic sheep using the Csf1r-based lentivirus is currently under-
way, and initial analysis of peripheral blood mononuclear cell in 
these animals shows EGFP expression is restricted to CD14+ mono-
cytes (unpublished data). We have shown that macrophages from 
chicken, cow, human, and pig as well as sheep alveolar macrophages 
can also be transduced with the vector, and express EGFP, so the 
mouse sequence provides a generic vehicle that could be tested in 
both veterinary, preclinical, and human clinical applications.
This remarkable cross-species reactivity highlights the widespread 
implications that this vector could have in current gene therapy tech-
nologies. If the Csf1r:EGFP-FIRE lentivirus is to be used as a gene ther-
apy vehicle, it would be advantageous to further decrease the size 
of the vector in order for sequences larger than EGFP to be inserted. 
The smaller vector we created apparently reduced expression and 
the titer of the two lentiviruses was similar, indicating the larger vec-
tor was not inhibiting virus production (data not shown). We may be 
able to optimize expression further by creating a hybrid or synthetic 
combination of FIRE (which is only around 300 bp) and the upstream 
element. What is clearly the case is that the enhancer can be located 
conveniently downstream of the gene of interest or reporter gene, so 
further optimization will be straightforward. The safety concerns of 
using lentiviral vectors in gene therapy technologies are well docu-
mented. There is the risk of insertional mutagenesis following viral 
transduction and current gene therapy research focuses on the use of 
integrase-deficient packaging plasmids.32 If Csf1r:EGFP-FIRE were to 
be used in clinical settings, it would be quite simple to mutate (D64V) 
the viral integrase, which decreases integration up to 104-fold.33
Aside from gene therapy, lentiviral vectors have also been 
considered as vaccines34 to drive efficient antigen expression 
and presentation in APC both in vitro and in vivo, leading to the 
activation of cellular immunity and humoral immune responses. 
The injection of a lentivirus containing ovalbumin driven by a 
ubiquitous promoter protected mice from the development of 
OVA-expressing tumor cells.35 However, in some cases, ubiqui-
tous expression of a potential antigen in non-APC could poten-
tially drive peripheral tolerance, rather than effective immuniza-
tion (e.g., ref. 36). The Csf1r lentivirus addresses this question by 
Figure 4 Murine Csf1r:EGFP-FIRE transduced primary macrophages from 
multiple species express EGFP. The following cells were differentiated into 
macrophages with rhCSF1 and then transduced with the lentivirus: (a) pig 
bone marrow–derived macrophages (BMDM), (b) cow monocyte-derived 
macrophages (MDM), (c) human MDM. A chicken macrophage cell line, 
HD11 (d) and sheep alveolar macrophages (e) were also transduced. These 
cells were not selected in blasticidin. Bar = 20 µm. Transductions were 
performed at least twice for each cell type.
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driving expression in professional APC. Classical Steinman–Cohn 
dendritic cells as well as macrophages express Csf1r-EGFP in the 
MacGreen mouse.37 As Csf1r:EGFP-sFIRE is only 5.3 kb between 
LTRs, there is the possibility to insert larger antigens for which 
previous vaccination approaches have proved difficult. One such 
example is the blood-stage of malaria. There is currently no vac-
cine and previous attempts at production have been hampered 
by the size of the antigens.38
In summary, we have created a lentiviral vector that drives expres-
sion of genes of interest in macrophage lineage cells of species from 
birds through livestock to humans.
MATERIALS AND METHODS
Constructs
Lentiviral vector plasmid pLenti6-R4R2-V5DEST (Invitrogen, Paisley, UK) was 
modified by removal of the attR4-attR2 region with EcoRV and self-ligation. 
The resultant plasmid was cut with ClaI/HpaI and a polymerase chain reac-
tion (PCR) product encoding central polypurine tract inserted. Two genomic 
DNA regions containing the FIRE were amplified by PCR and cloned into the 
XbaI site. The sizes of the genomic DNA containing FIRE were 1,798 bp and 
537 bp, respectively. The murine Csf1r promoter (mm10, chr18:61,105,457-
61,105,950) was amplified via splice overlap PCR so that the ATG of Csf1r 
initiates translation of EGFP. The construct used to produce MacGreen mice 
was used as template DNA.12 The Csf1r promoter:EGFP fragment was cloned 
into the EcoRV site upstream of FIRE. A construct was also created where 
mCherry replaced EGFP. mCherry or EGFP was also fused to a myristoylated 
motif (myr) to localize expression to membranes. The vector containing 
myr:mCherry39 was a generous gift from Mary E. Dickinson (Baylor College of 
Medicine, Houston, TX). A list of oligonucleotides used in the construction of 
these vectors can be found in Table 1.
Cell culture
All cells were maintained at 37 °C in a humidified 5% CO2 incubator and 
cultured as per Table 2. All media contained 1 mmol/l GlutaMAX (Life 
Technologies, Paisley, UK) except for rat BM, which contained 2 mmol/l. If 
cells were selected with blasticidin following lentiviral transduction, the con-
centration is listed in Table 2.
Lentivirus production and titration
High-titer lentivirus was prepared by transfection of HEK293T cells with a 
Csf1r construct as well as psPax2 (encoding gag/pol/rev proteins) and pLP/
vesicular stomatitis virus G (for the expression of vesicular stomatitis virus G 
glycoprotein). Prior to transfection, HEK293T cells were plated at 105 cells/
cm2 and cotransfection of the three plasmids was performed with Fugene 
HD (Promega, Southampton, UK) according to manufacturer’s instructions. 
The following day medium was replaced with serum-free culture media. 
Supernatant was harvested 48 hours post-transfection and filtered through 
0.45 µm filters prior to concentration in Centricon Plus-70 columns (Millipore, 
Watford, UK). Once the supernatant was concentrated to 10 ml, it was then 
ultracentrifuged for 2 hours at 69K xg at 4 °C. Viral pellets were resuspended 
in 100 mmol/l NaCl, 20 mmol/l Tris pH 7.3, 10 mg/ml sucrose, and 10 mg/
ml mannitol and stored at −80 °C until use. The viral titer (typically between 
8.5 × 107 and 2 × 108 transducing units/ml) was assayed by end-point dilution 
on the D-17 cell line. For some experiments, unconcentrated lentivirus (105 
transducing units/ml) was used.
Table 1 Oligonucleotides used in cloning 
Oligonucleotide Sequence/s
Mouse Csf1r promoter 5′ TTACCAGTTGGTCCCAGAGG
Csf1r:EGFP splice overlap 5′ CACGCTATCCCCTGGAGACTATGGTGAGCAAGGGCG;  
3′ AACAGCTCCTCGCCCTTGCTCACCATAGTCTCCAGGGGATAGCGTGAGCC
EGFP 3′ GCGGCCGCTTTACTTGT
FIRE 5′ GAGTGTGTGAGTGGCTGCAT; 3′ AGACCATCCATCCTCCTCCT
sFIRE 5′ GGGTCAGCAAACAGGACAGT; 3′ TCCCCTGCTCCAGTACAGAC
Csf1r:myrEGFP splice overlap 5′ CACGCTATCCCCTGGAGACTATGGGCTGCATCAAGAGCAAG; 
3′ GCGCTTGCTCTTGATGCAGCCCATAGTCTCCAGGGGATAGCGTGAGCC
myr:EGFP splice overlap 5′ CGACGACGAGGCACCGGTCGCCACCATGGTGAGCAAGGGC;  
3′ GCCCTTGCTCACCATGGTGGCGACCGGTGCCTCGTCGTCG
mCherry 3′ TTGAATTGCTCCTCGAGGCCG
Csf1r:mCherry splice overlap 5′ GGCTCACGCTATCCCCTGGAGACTATGGTGAGCAAGGGCGAGGAGGATAA; 
3′ TTATCCTCCTCGCCCTTGCTCACCATAGTCTCCAGGGGATAGCGTGAGCC
FIRE, Fms-intronic regulatory element.
Table 2 Cell culture media 
Cells Media Polybrene 
(µg/ml)
Blasticidin 
(µg/ml)
RAW264.7 DMEM, 10% FCS 8 5
HEK293T,D-17 DMEM, 10% FCS, 100 U/ml penicillin, 100 µg/ml streptomycin, nonessential amino acids 8 (D-17) 15 (D-17)
EL4 DMEM, 10% horse serum 8 10
HD11 RPMI, 10% FCS, 2% chicken serum 8 7.5
Rat BM, rat BMDM DMEM, 10% FCS, 100 U/ml penicillin, 100 µg/ml streptomycin 5 8 (Rat BM)
BMDM, bone marrow–derived macrophages; DMEM, Dulbecco's modified Eagle medium; RPMI, Roswell Park Memorial Institute medium.
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Lentiviral transduction
Cells were cultured in 24-well plates or Lab-Tek II 4-well chamber slides and 
on the morning of transduction, placed in a minimal volume of media con-
taining polybrene and lentivirus (as specified in more detailed protocols 
below and in Table 2). Cells were incubated at 37 °C for 3–4 hours before the 
wells were topped up with 1 ml fresh media.
Lentiviral transduction of cell lines
EL4 and RAW264.7 cells were transduced with 9.2 × 104 transducing units of 
lentivirus (Figure 2a). Unconcentrated virus was used to transduce RAW264.7 
cells in Figure 2c.
FACS analysis of RAW264.7 cells
RAW264.7 cells were harvested and placed in PBS containing 2% fetal calf 
serum (FCS) and 1 µg/ml propidium iodide (Sigma, Dorset, UK) to exclude 
dead cells. EGFP expression was analyzed on a FACSCalibur (BD, Oxford, UK).
Microscopy
Cells were imaged via confocal microscopy using either an eC1 (Nikon, 
Kingston Upon Thames, UK) or LSM710 (Zeiss, Cambridge, UK). Standard 
light microscopes were also used. For detection of EGFP expression in mac-
rophages from multiple species, EGFP gain was initially set using untrans-
duced cells and the same EGFP gain used for all samples.
Lentiviral transduction of rat BM-derived macrophages
All animal care and experimentation was conducted in accordance with 
guidelines of Roslin Institute and the University of Edinburgh and under 
Home Office Project License PPL 60/4259. Cryopreserved BM cells from a 
male Wistar rat were thawed and cultured on bacteriological plates as per 
Table 2 in media containing 104 U/ml (100 ng/ml) recombinant human CSF1 
(rhCSF1, a gift from Chiron, Emeryville, CA). On day 8, 1.9 × 105 cells/well were 
plated in a 24-well plate and transduced the following day with Csf1r:EGFP-
FIRE with 4 × 104 transducing units of lentivirus.
Lentiviral transduction of rat BM
BM cells from an 8-week-old male Dark Agouti rat were isolated from femurs 
by flushing the bones with cell culture media. Red blood cells were removed 
using lysis buffer (BioLegend, London, UK) according to instructions. Cells 
were cultured at a concentration of 1 × 106 cells/ml in media (Table 2) con-
taining 10 ng/ml rat IL-3b (Peprotech, London, UK), 100 ng/ml murine stem 
cell factor, and 50 ng/ml murine IL-6 (Sigma). The following day cells were 
concentrated back to 1 × 106 cells/ml via centrifugation. On day 2, cells were 
transduced with 1.2 × 105 transducing units of Csf1r:EGFP-FIRE lentivirus. 
Media was replaced the following day and on day 4, rhCSF1 (104 U/ml) was 
added for macrophage differentiation. In experiments where BM was FACS 
sorted for EGFP expression, cells were harvested as described above and 
cultured in 15% FCS, penicillin, streptomycin, 50 µmol/l 2-Mercaptoethanol, 
2 mmol/l GlutaMAX, 50 ng/ml murine IL-6, 120 ng/ml murine FLT3-L, 50 ng/
ml rat thrombopoietin, and 100 ng/ml murine SCF (Sigma). Cells were con-
centrated to 1 × 106 cells/ml and transduced on day 2 as described above. 
On day 3, the media was replaced and on day 4 Blasticidin (8 µg/ml) was 
added to select for transduced cells. Cells were cultured for 3 weeks before 
EGFP positive and negative cells were sorted on a FACSAria III (BD). SYTOX 
Blue (Invitrogen) was used to exclude dead cells. Following cell sorting, cells 
were centrifuged and RNA isolated using an RNeasy Mini kit (QIAGEN, Venlo, 
Netherlands) according to instructions.
Phagocytosis assay
Phagocytosis assays were performed as described on www.macrophages.
com. Zymosan A BioParticles labeled with Alexa Fluor 594 (Invitrogen) were 
used.
cDNA synthesis and PCR
DNA was removed from RNA with Ambion DNA-free and cDNA pre-
pared using SuperScript III reverse transcriptase and random hexam-
ers (Invitrogen). Rat Actb and Csf1r were amplified from EGFP− and EGFP+ 
cells with Invitrogen Taq polymerase using the following oligonucle-
otides. Actb 5′ caaccttcttgcagctcctc, ActB 3′ ctctcagctgtggtggtgaa, Csf1r 5′ 
AGGAAGCTGTGCTGCCCTGT, and Csf1r 3′ CTCCCCTCGAATCCTCACCA.
Isolation of primary macrophages from multiple species
Pig BM-derived macrophages, cow, and human monocyte-derived macro-
phages were derived according to protocols described in ref. 40–42 respec-
tively. Sheep alveolar macrophages were isolated as per ref. 43 and cultured 
in Roswell Park Memorial Institute medium containing 20% sheep serum 
containing 104 U/ml (100 ng/ml) rhCSF1.
Lentiviral transduction of macrophages from multiple species
All cells were transduced with 2 × 105 transducing units of lentivirus in media 
containing 8 µg/ml polybrene except for human and pig monocyte-derived 
macrophages, which were transduced with unconcentrated lentivirus.
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